Qualitative assessment of the scale-up of COVID-19 testing network in Armenia: turning adversities into opportunities.

Publication date: Feb 14, 2025

The COVID-19 pandemic reaffirmed the importance of high-quality laboratory services in the face of elevated demand for timely COVID-19 laboratory diagnosis. We explored the scale-up experience of the laboratory system in Armenia as well as the successes and challenges it brought to the overall laboratory system with the aim to identify lessons that can serve as opportunities for improvement. We conducted a qualitative study to explore the experiences concerning the process of scale-up of the COVID-19 testing network through in-depth interviews with policymakers/experts (n = 6), heads (n = 6) and physicians (n = 3) of private and public laboratories conducting COVID-19 testing. Eight domains of the WHO Laboratory Assessment Tool System (S-LAT) questionnaire guided the study and directed the content analysis. According to the findings, within the COVID-19 testing network, numerous advancements were documented across all essential elements of the S-LAT as a result of the COVID-19 response. The most vivid improvements were related to the newly established network of public and private laboratories for COVID-19 testing and related coordination mechanisms, new laboratory information management practices, improved compliance with biosafety measures, novel quality assurance mechanisms as well as improved technical and human resources. However, suboptimal coordination of the COVID-19 testing network and the whole laboratory system, the gap between existing and proper biosafety management and quality control practices, and insufficient training of laboratory professionals were mentioned as potential challenges for the laboratory system in the future. The assessment revealed challenges and achievements of the laboratory system during the COVID-19 response. Enhancement of coordination and cooperation mechanisms within and beyond the COVID-19 testing network, continuous improvement of human resources as well as quality and biosafety control practices throughout the whole system are crucial for sustaining the achievements and for strengthening future preparedness of the laboratory system to infectious disease outbreaks.

Open Access PDF

Concepts Keywords
Armenia Armenia
Conducting COVID-19
Covid COVID-19 response
Pandemic COVID-19 Testing
Policymakers Humans
Interviews as Topic
Laboratories
Laboratory preparedness
Laboratory system
Qualitative Research
S-LAT
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19
disease IDO quality
disease IDO process
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH Long Covid
pathway REACTOME Reproduction
drug DRUGBANK Serine
drug DRUGBANK Tretamine
disease IDO contact tracing
disease MESH infection transmission
drug DRUGBANK Gold
disease IDO facility
disease MESH infection
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH AIDS
disease MESH malaria
pathway KEGG Malaria
disease MESH poliomyelitis
disease MESH diphtheria
disease MESH influenza
disease IDO country
disease MESH emergency
drug DRUGBANK Trestolone
drug DRUGBANK Etoperidone
drug DRUGBANK Coenzyme M
drug DRUGBANK Ademetionine
disease IDO site
drug DRUGBANK Spinosad
disease MESH reemerging infectious diseases
disease MESH avian flu

Original Article

(Visited 2 times, 1 visits today)